Setback
Keytruda-Lenvima combo fails to improve survival in two lung cancer trials
Anika Sharma
Merck and Eisai’s collaborative effort with Keytruda and Lenvima faces yet another setback in their quest to combat cancer. Despite ...
Mirati’s KRAS Inhibitor Krazati Faces Rejection in Europe
SG Tylor
Source – Mirati Therapeutics Mirati Therapeutics has faced a setback in its quest to market its lead KRAS inhibitor Krazati, ...
